Viewing data from:

GABAPENTIN

ANDA

GABAPENTIN | A203934 | ZYDUS PHARMACEUTICALS USA INC

5 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: GRALISE(TE code: AB2)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 2 NDCs

Highest NADAC/Unit

$0.9433

per ea

Lowest NADAC/Unit

$0.7249

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
68382060716GABAPENTIN ER 600 MG TABLET	$0.9433	EA	Generic	—	2026-08-19
68382060816GABAPENTIN ER 300 MG TABLET	$0.7249	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain24 active DMFs12 inactive

21 active API suppliers hold Drug Master Files for this ingredient.

TAPI NL BVGABAPENTIN

DMF 127361997

FIS FABBRICA ITALIANA SINTETICI SPAGABAPENTIN

DMF 140241999

HIKAL LTDGABAPENTIN USP

DMF 160602002

TARO PHARMACEUTICAL INDUSTRIES LTDGABAPENTIN USP

DMF 161512002

SUVEN PHARMACEUTICALS LTDGABAPENTIN USP

DMF 170632003

SUN PHARMACEUTICAL INDUSTRIES LTDGABAPENTIN USP

DMF 172402004

SOLARA ACTIVE PHARMA SCIENCES LTDGABAPENTIN USP

DMF 175432004

OLON SPAGABAPENTIN

DMF 181712005

MATRIX PHARMACORP PRIVATE LTDGABAPENTIN USP

DMF 182252005

DIVIS LABORATORIES LTDGABAPENTIN USP

DMF 190002005

APITORIA PHARMA PRIVATE LTDGABAPENTIN USP (NON-STERILE DRUG SUBSTANCE)

DMF 201222006

ZHEJIANG CHIRAL MEDICINE CHEMICALS CO LTDGABAPENTIN

DMF 208262007

ANJAN DRUG PRIVATE LTDGABAPENTIN USP

DMF 227652009

JIANGXI SYNERGY PHARMACEUTICAL CO LTDGABAPENTIN

DMF 258252012

HETERO DRUGS LTDGABAPENTIN

DMF 261312012

ZHEJIANG EXCEL PHARMACEUTICAL CO LTDGABAPENTIN USP

DMF 265142012

TAPI NL BVGABAPENTIN BUTANOL PROCESS

DMF 271242013

SARACA LABORATORIES LTDGABAPENTIN USP

DMF 308092017

HETERO DRUGS LTDGABAPENTIN (PROCESS-II)

DMF 318192017

JIANGXI SYNERGY PHARMACEUTICAL CO LTDGABAPENTIN (E)

DMF 343152020

ZHEJIANG HUAHAI PHARMACEUTICAL CO LTDGABAPENTIN USP

DMF 362412021

EMNAR PHARMA PRIVATE LTDGABAPENTIN USP

DMF 370282022

ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO LTDGABAPENTIN

DMF 372432022

ZHEJIANG BAMBOO PHARMACEUTICALS CO LTDGABAPENTIN

DMF 377612023

MEDICHEM SAInactiveGABAPENTIN, DRUG SUBSTANCE

DMF 131781998

ERREGIERRE SPAInactiveGABAPENTIN

DMF 155132001

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveGABAPENTIN USP (NON-STERILE BULK)

DMF 162872002

PROCOS SPAInactiveGABAPENTIN

DMF 163422002

ERREGIERRE SPAInactiveGABAPENTIN

DMF 173512004

SANDOZ INDUSTRIAL PRODUCTS SAInactiveGABAPENTIN (NON-STERILE BULK)

DMF 184892005

JIANGSU NHWA PHARMACEUTICAL CO LTDInactiveGABAPENTIN

DMF 206452007

JIANGXI SYNERGY PHARMACEUTICAL CO LTDInactiveGABAPENTIN

DMF 214012008

JIANGSU HENGRUI PHARMACEUTICALS CO LTDInactiveGABAPENTIN, USP, NON-STERILE, BULK DRUG SUBSTANCE

DMF 220152008

GRANULES INDIA LTDInactiveGABAPENTIN USP

DMF 335362019

IOL CHEMICALS AND PHARMACEUTICALS LTDInactiveGABAPENTIN USP

DMF 365362022

ZHEJIANG APELOA JIAYUAN PHARMACEUTICAL CO LTDInactiveGABAPENTIN

DMF 413112025

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Mar 14, 2023	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (5)

Sort:

#001 — 300MG

AB2

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jan 24, 2024

No patent or exclusivity listings for this strength.

#002 — 600MG

AB2

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jan 24, 2024

#003 — 450MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Aug 25, 2025

#004 — 750MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Aug 25, 2025

#005 — 900MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Aug 25, 2025